Physician profile
Kyle Wiseman
NPI 1619506821
$2,807.64
in general payments reported to CMS, 2019-2025
20 companies · $1,640 in 2025
The $1,640 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $332 · 2024: $835 · 2025: $1,640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,596 · Education: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,596.27 |
| Education | $211.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $663.95 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $441.64 | 2024-2025 | Impella |
| Abbott Laboratories | $259.42 | 2025 | Mitraclip, Diamondback Coronary |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $214.62 | 2024-2025 | Lifevest |
| Medtronic, INC. | $200.06 | 2025 | Corevalve Evolut R, Azure Xt Dr Mri Surescan |
| Astrazeneca Pharmaceuticals LP | $197.42 | 2024-2025 | Wainua |
| Edwards Lifesciences Corporation | $162.87 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novartis Pharmaceuticals Corporation | $115.92 | 2024-2025 | |
| Chiesi USA, INC. | $105.96 | 2023-2025 | Kengreal |
| Pfizer INC. | $105.47 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $76.47 | 2024-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.73 | 2023-2024 | Jardiance |
| Cardiva Medical, INC. | $47.60 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Scpharmaceuticals INC. | $39.75 | 2024-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $32.35 | 2023 | Arcalyst |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $17.81 | 2024 | Assure Wcd |
| Ancora Heart, INC. | $17.42 | 2024 | Accucinch |
| Janssen Pharmaceuticals, INC | $17.00 | 2024 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $16.96 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $14.22 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Wiseman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.